A phase II, multicenter, single-arm study of Herceptin (trastuzumab) in subjects with HER2-overexpressing colorectal cancer who have not received prior cytotoxic chemotherapy for metastatic disease
Phase of Trial: Phase II
Latest Information Update: 13 Dec 2005
At a glance
- Drugs Trastuzumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 13 Dec 2005 New trial record.